track a basic science report

22
www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 20 TRACK A BASIC science report

Upload: shen

Post on 24-Feb-2016

36 views

Category:

Documents


0 download

DESCRIPTION

TRACK A BASIC science report. TRACK A : BASIC science. THE TEAM. Nichole Klatt USA. Uriel Moreno-Nieves Mexico. Clovis Palmer Australia. and behind the stage….the IAS people !!. TRACK A : the KEY words. Immune activation and Inflammation Mucosal infection Acute infection - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

TRACK A

BASIC science report

Page 2: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

TRACK A : BASIC scienceTHE TEAM

Nichole KlattUSA

Clovis PalmerAustralia

Uriel Moreno-NievesMexico

and behind the stage….the IAS people !!

Page 3: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

TRACK A : the KEY words

• Immune activation and Inflammation• Mucosal infection• Acute infection• Myeloid cells• Restriction factors• Reservoir• Recovery

SIV

mod

el :

path

ogen

inc

vs n

on p

atho

geni

c

HIV

Page 4: TRACK A  BASIC science report

Klatt et al. Immunol Rev 2013

Page 5: TRACK A  BASIC science report

Microbial translocation

InflammationCoagulation

Odds of Mortality (4th vs 1st Quartile)(Independent of CD4 count and virus load)

Markers of Inflammation and GI Dysfunction Predict Mortality

%CD38+DR+

%CD57+DR+

T cells

Innate activation is a stronger predictor of death than T cell activation

OTHER markers (IP10, CD163, et al) to add to

(HUNT)

Page 6: TRACK A  BASIC science report

Monocyte cellular phenotypes are independently linked to IL-6, CRP and D-dimer

Monocyte Phenotype (%) OR (95% CI) for CAC Progression* p-valueCD14+/CD16+ 1.65 (1.08, 2.52) 0.02CD14dim/CD16+ 1.36 (0.98, 1.88) 0.06CD14var/CD16+ 1.69 (1.12, 2.54) 0.01*CAC Progression defined as ‘B’ or ‘C’ above; OR per 1% greater frequency of given phenotype, adjusted for age, gender, race, smoking, diabetes, hepatitis B or C co-infection, current CD4 count, HIV RNA <400 copies/mL, and cholesterol and blood pressure lowering treatment

Monocyte Activation Independently Predicts Greater 2-yr Coronary Artery Calcium Progression (SUN Study)

I. SERETIROLE In CARDIOVASCULAR DISEASE

Page 7: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

Myeloid cells matter…..

Dysregulation of Metabolic pathways

Non-communicable diseases

Reservoir of HIVAnd approaches to release

HIV-related dementia

Opportunistic infections

IRIS

Borrowed from Crowe

(Anzinger)

(F. Graziano)

(M.I. Sada-Ovalle)(H.Tran)

Page 8: TRACK A  BASIC science report

The Lymph node : a major player

Page 9: TRACK A  BASIC science report

By T. SchackerLYMPH NODE FIBROSIS in HIV infection

Page 10: TRACK A  BASIC science report

Start ARV

Pirfenidone (anti-fibrotic) therapy in macaque is associated with preservation of LN CD4 T cell population

(Schacker)

Page 11: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

Probiotics + ARV in SIV infected macaques decreased fibrosis and enhanced CD4 reconstitution

In the gut : fibrosis and CD4 loss N. Klatt

Page 12: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

ACE/ARBsSchacker/UMHatano/UCSFSandler/ACTG

Anti-IL-6Lederman/CWRU

RifaximinTenorio/ACTG

Hsue/UCSF

SevelamerSandler/ACTG

MesalamineSomsouk/UCSF

StatinsNixon/ACTG

MethotrexateHsue/ACTG

ChloroquineJacobson/ACTG

IsotretinoinKwon/ACTG

CLINICAL trials to decrease immune activation: Many approaches are in the field

or are planned

Courtesy of S. Deeks & P. Hunt, with permission from M.P.

Page 13: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

Attention to unexpected results: peg-IFN alpha vs. type I IFN R antagonist

MACAQUE STUDY interphering with type I IFN pathway to protected from disease.

Although administration of IFNa delayed acquisition of the infection, both treatments

accelerated progression to disease. D. Douek

Page 14: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

Where is the virus….hidden ?• Full RNA transcription (highest levels) is associated with

CD4 down regulation in vivo (Koup)• In lymph nodes of SIV loss of T cell in paracortical area and

expansion of in germinal center. The GC CD4 cells are highly infected. >> GC hypertrophy >> higher immune activation (Koup)

• T Follicular cells are supporting HIV infection and replication.

• Tscm (memory stem cells, long-lived, pluripotent) are infected but do contribute little to the total reservoir (Silvestri and Lichterfeld)

Page 15: TRACK A  BASIC science report

CD4+ TSCM are numerically preserved during BOTH pathogenic and nonpathogenic SIV infections.

G. SILVESTRI

Robust levels of CD4+TSCM infection in vivo are observed in SIV-infected RMs but not in SIV-infected SMs.

Page 16: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

Tscm in HIV infection

• Tscm are a cell reservoir with the highest DNA content compared to other T cell subsets. The contribution to the total reservoir is not high, as Tscm represent 2-3% of all T cells, BUT is consistent in time.

Can the virus in Tscm be eradicated ?• Susceptibility of TSCM and TCM to HDACi in vitro but in vivo not

clear.• Beta-catenin inhibitors induce differentiation of TSCM and TCM

into more short-lived CD4 T cell subsets.• Evidence for synergistic activity of HDACi and beta-catenin

inhibitors for increasing chromatin acetylation and HIV-1 reactivation.

M. Lichterfeld

Page 17: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

When limit the virus ? SPARTAC (John Frater)

VISCONTI (French study group)

RV254 (Jintanat Ananworanich)

Boston cohort (Marcus Altfeld)

ELITE controllers (Olivier Lambotte)

…….

ANRS workshop

THE EARLIER THE BEST !! ??

Page 18: TRACK A  BASIC science report

www.ias2013.org Kuala Lumpur, Malaysia , 30 June - 3 July 2013

How to regulate the virus ?New players and old ones with new functions

• BST2/Tetherin (isoforms): promote HIV release, but interphere with pDC antiviral responses (control INFa release). (Cohen)

• ERAP2 (ER aminopeptidase) : trims peptides for optima MHC1 presentation (haplotypes) : different resistance to HIV infection. (Salle)

• CTP2 : multifunctional cellular factor establishment of latency/HDAC and inhibits viral reactivation/P-TEFb (Rohr. HIVCure)

• p21 : repression of the dNTP biosynthetic enzyme RNR2 to restrict HIV reverse transcription in macrophages (Pancino)

• SAMHD1 : is inhibited by infected DC/Tcell crosstalk (Su) and in Elite controllers (Martin-Gayo)

• LEDGF/p75 and TNPO3 : altered HIV replication (pre and integration) in mDC of elite controllers (Martin-Gayo)

OTHERS to come…. Potential targets for new therapies

Page 19: TRACK A  BASIC science report

HIV PREVENTION Symposium Vaccine Efficacy Trials

NOTE: Phambili (HVTN 503) began to explore a regime similar to STEP in South Africa (not included).

No

From Diffenbach

Page 20: TRACK A  BASIC science report

>12Abs

1

>25

>25>5

gp41

gp120

viralmembrane

MPER(10E8)CD4bs

(VRC01)

V3 / V4 / glycans(cluster of targets:

PGT120s, PGT130s)

Glycans(2G12)

V1/V2 / glycans(PG9)

V3/CD4i(3BC176)2

N332 Abs

HIV is vulnerable : bnMAbs show sites

that could be targeted by vaccine-induced

Abs

Page 21: TRACK A  BASIC science report

Rational HIV immunogen design to target specific germline B cell receptors.

Jardine, Science 2013

“N322 gp120 moAbs series“ ….. PGT121D. BurtonGermline sequencing

Neutralization strength (IC50)

Neu

tral

izatio

n Br

eath

(n o

f iso

late

s)

100%

low high

PGT121

Precursor

Precursor

? Do we need the most potent or is a pool of intermediate sufficient ?

Page 22: TRACK A  BASIC science report

Klatt et al. Immunol Rev 2013

To complete the gaps

MORE BASIC RESEARCH